Skip to main content

Oral question asked in the House of Lords, by Lord Kennet (Labour). It was answered by Baroness Trumpington (Conservative) on Monday, 16 July 1990.


Oral question

Question
Whether genetically engineered hormone BST would, if licensed, qualify as a "state of the art" product, liability for compensation for damage from which would not fall on the manufacturers

Secondary information

Type
Oral question
Reference
521 c742-3 
Session
1989-90
Oral question type
Lead
Chamber / Committee
House of Lords chamber
Subjects
Compensation Cattle Licensing Liability Hormone treatments Bovine somatotropin